Do the benefits of using calcitriol and other vitamin D receptor activators in patients with chronic kidney disease outweigh the harms?

Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease

(2016) Stuart M. Sprague et al.   AMERICAN JOURNAL OF NEPHROLOGY

The use of vitamin D analogs is independently associated with the favorable renal prognosis in chronic kidney disease stages 4–5: the CKD-ROUTE study

(2016) Yohei Arai et al.   Clinical and Experimental Nephrology

A Randomized Trial of Cinacalcet versus Vitamin D Analogs as Monotherapy in Secondary Hyperparathyroidism (PARADIGM)

(2015) J. B. Wetmore et al.   Clinical Journal of the American Society of Nephrology

Revisiting KDIGO clinical practice guideline on chronic kidney disease—mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference

(2015) Markus Ketteler et al.   KIDNEY INTERNATIONAL

Effect of active vitamin D on cardiovascular outcomes in predialysis chronic kidney diseases: A systematic review and meta-analysis

(2015) Xiao-Hua Li et al.   NEPHROLOGY

A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3-4 CKD

(2014) D. W. Coyne et al.   Clinical Journal of the American Society of Nephrology

Impact of Vitamin D on Chronic Kidney Diseases in Non-Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials

(2014) Lijuan Xu et al.   PLoS One

Cholecalciferol (Vitamin D3) Therapy and Vitamin D Insufficiency in Patients with Chronic Kidney Disease: A Randomized Controlled Pilot Study

(2013) Prakash Chandra et al.   Endocrine Practice

Active Vitamin D Treatment for Reduction of Residual Proteinuria: A Systematic Review

(2013) M. H. de Borst et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Effect of Paricalcitol on Left Ventricular Mass and Function in CKD--The OPERA Trial

(2013) A. Y.-M. Wang et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Vitamin D receptor activation: cardiovascular and renal implications

(2013) Sagar U. Nigwekar et al.   Kidney International Supplements

Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease

(2012) Ravi Thadhani et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Extra-skeletal effects of vitamin D deficiency in chronic kidney disease

(2011) Michel Chonchol et al.   ANNALS OF MEDICINE

Vitamin D

(2011) Yan C. Li   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease

(2010) S. M. Moe et al.   Clinical Journal of the American Society of Nephrology

Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial

(2010) Dick de Zeeuw et al.   LANCET

Oral Paricalcitol in the Treatment of Patients With CKD and Proteinuria: A Randomized Trial

(2009) Steven Fishbane et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients

(2008) F.C. Barreto et al.   KIDNEY INTERNATIONAL

Oral active vitamin D is associated with improved survival in hemodialysis patients

(2008) Manuel Naves-Díaz et al.   KIDNEY INTERNATIONAL

The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study

(2008) F. Tentori et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION